Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Shares Bought by Charles Schwab Investment Management Inc.
Charles Schwab Investment Management Inc. raised its holdings in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 0.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 906,646 shares of the biopharmaceutical company’s stock after acquiring an additional 1,737 shares during the […]
